European Medicines Agency (EMA) | What's new Follow Orphan designation: Infigratinib Treatment of achondroplasia, 19/07/2021 Positive https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-21-2475 ema.europa.eu
